GOODWILL AND OTHER INTANGIBLE ASSETS, NET

3 Months Ended

Mar. 31, 2026

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS, NET

GOODWILL AND OTHER INTANGIBLE ASSETS, NET

Goodwill

The following is a reconciliation of goodwill by segment.

(in millions)	Medical Products & Therapies		Healthcare Systems & Technologies		Pharmaceuticals		Total
Balance as of December 31, 2025	$	1,265	$	3,087	$	577	$	4,929
Currency translation	(17)		(5)		(8)		(30)
Balance as of March 31, 2026	$	1,248	$	3,082	$	569	$	4,899

Other intangible assets, net

The following is a summary of our other intangible assets.

									Indefinite-lived intangible assets
(in millions)	Customer relationships		Developed technology, including patents		Trade names		Other amortized intangible assets		Trade names		In process Research and Development		Total
December 31, 2025
Gross other intangible assets	$	3,393	$	3,208	$	953	$	91	$	390	$	107	$	8,142
Accumulated amortization	(1,095)		(2,434)		(172)		(72)		—		—		(3,773)
Other intangible assets, net	$	2,298	774		781		19		390		107		4,369
March 31, 2026
Gross other intangible assets	$	3,392	$	3,194	$	953	$	90	$	390	$	107	$	8,126
Accumulated amortization	(1,148)		(2,498)		(190)		(72)		—		—		(3,908)
Other intangible assets, net	$	2,244	$	696	$	763	$	18	$	390	$	107	$	4,218

Intangible asset amortization expense was $146 million and $155 million for the three months ended March 31, 2026 and 2025, respectively.